Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S21 pseudogene 8 (RPS21P8) is a non-protein-coding processed pseudogene related to the ribosomal protein S21 gene family[7][1]. Pseudogenes like RPS21P8 are the result of duplication or retrotransposition events that render them non-functional; they do not encode active proteins and typically have no direct role in cellular biology or disease[7][1]. RPS21P8 is not considered a druggable target, is not involved in any signaling pathways, and has no known relevance as a biomarker or in therapeutic development. Key clarification: The ribosomal protein S21 gene (RPS21) is a functional component of the cytoplasmic 40S ribosomal subunit involved in protein synthesis[4][5]. By contrast, "RPS21P8" specifically refers to a pseudogene variant and is not biologically active[7]. Summary: "RPS21P8" is a pseudogene, not a protein-encoding target, and should not be used as a basis for drug targeting or biological intervention[7]. The canonical full name and abbreviation are correctly stated but its classification as a target is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S21 pseudogene 8 (RPS21P8).